120 related articles for article (PubMed ID: 8019773)
21. CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification.
Branchereau P; Böhme GA; Champagnat J; Morin-Surun MP; Durieux C; Blanchard JC; Roques BP; Denavit-Saubié M
J Pharmacol Exp Ther; 1992 Mar; 260(3):1433-40. PubMed ID: 1545402
[TBL] [Abstract][Full Text] [Related]
22. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.
Dauge V; Bohme GA; Crawley JN; Durieux C; Stutzmann JM; Feger J; Blanchard JC; Roques BP
Synapse; 1990; 6(1):73-80. PubMed ID: 2399491
[TBL] [Abstract][Full Text] [Related]
23. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
24. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin-A receptor mediation of food intake in cats.
Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
[TBL] [Abstract][Full Text] [Related]
26. Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.
Goudie AJ; Leathley MJ
Psychopharmacology (Berl); 1995 Mar; 118(1):57-64. PubMed ID: 7597123
[TBL] [Abstract][Full Text] [Related]
27. The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats.
Derrien M; Daugé V; Blommaert A; Roques BP
Behav Brain Res; 1994 Dec; 65(2):139-46. PubMed ID: 7718145
[TBL] [Abstract][Full Text] [Related]
28. Antiallodynic effects of a CCKB antagonist in rats with nerve ligation injury: role of endogenous enkephalins.
Nichols ML; Bian D; Ossipov MH; Malan TP; Porreca F
Neurosci Lett; 1996 Sep; 215(3):161-4. PubMed ID: 8899738
[TBL] [Abstract][Full Text] [Related]
29. Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport.
Rao RK; Levenson S; Fang SN; Hruby VJ; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1994 Feb; 268(2):1003-9. PubMed ID: 8113956
[TBL] [Abstract][Full Text] [Related]
30. Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation.
Sebret A; Léna I; Crété D; Matsui T; Roques BP; Daugé V
J Neurosci; 1999 Aug; 19(16):7230-7. PubMed ID: 10436075
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
32. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
[TBL] [Abstract][Full Text] [Related]
33. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
[TBL] [Abstract][Full Text] [Related]
34. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
Weatherford SC; Chiruzzo FY; Laughton WB
Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
[TBL] [Abstract][Full Text] [Related]
35. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
[TBL] [Abstract][Full Text] [Related]
36. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat.
Harro J; Vasar E
Eur J Pharmacol; 1991 Feb; 193(3):379-81. PubMed ID: 2055248
[TBL] [Abstract][Full Text] [Related]
37. Effect of a highly selective central CCK-B receptor agonist: BC-264 on rat sleep.
de Saint Hilaire Z; Roques BP; Nicolaïdis S
Pharmacol Biochem Behav; 1991 Mar; 38(3):545-8. PubMed ID: 2068190
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.
Boden PR; Woodruff GN; Pinnock RD
Br J Pharmacol; 1991 Mar; 102(3):635-8. PubMed ID: 1364831
[TBL] [Abstract][Full Text] [Related]
39. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
40. Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test.
Filho CB; Del Fabbro L; de Gomes MG; Goes AT; Souza LC; Boeira SP; Jesse CR
Eur J Pharmacol; 2013 Jan; 698(1-3):286-91. PubMed ID: 23178563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
